Skip to content
Pages
Posts by category
- Category: Company Updates
- Shorla Oncology Announces U.S. FDA Approval of Nelarabine Injection for the Treatment of T-Cell Leukemia
- We were delighted to have been a presenting company at the BIOTECH Showcase 2023 in San Francisco recently!
- Join Shorla Oncology at the BIO CEO and Investor Conference 2023
- Join Shorla Oncology at the Biotech Showcase 2023
- Our CEO part of the “Cancer Across Borders – Ireland’s Reach” Panel Discussion
- Join Shorla Oncology at CPhI Frankfurt 2022
- Shorla Oncology at Bio Europe 2022
- Our CTO spoke on the founders panel at Scale Ireland’s Annual Event
- Our CEO spoke at the LSX World Congress USA in Boston
- Shorla Oncology at ASCO Annual Meeting, Chicago 2022
- Our CCO, Nicholas Holsman speaks at the MassBio Conference
- Shorla Oncology Appoints Dennis Purcell as Chairman
- Company Name Change: Shorla Pharma is now Shorla Oncology!
- Shorla Oncology at Bio CEO & Investor conference, New York 2022
- Shorla Oncology at Euronext IPO ready programme, Dublin 2022
- Shorla Oncology at ASH, Atlanta, Georgia 2021
- CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston
- Shorla Oncology at CPhI Worldwide in Milan
- Shorla Oncology at Asembia Specialty Pharmacy Summit
- Shorla recently welcomed the Minister of State for Business, Employment and Retail, Damien English to the Clonmel office
- Shorla Oncology at HLTH Boston 2021
- Shorla Oncology at Biotech Week Boston
- Reuters Global Pharma Awards – Finalist
- Shorla Oncology Announces Partnership with EVERSANA
- Shorla Oncology Expands into the U.S.
- Team Shorla Oncology complete 100k in 30 days for Breast Cancer
- FDA filing acceptance and priority review received for SH-111
- United Conference of Generics, Vaccines and Biosimilars
- 30 % Club Ireland
- Shorla Oncology Announces Chief Commercial Officer
- Shorla Oncology – Q&A with Tracy Woody
- John Moloney and Tracy Woody announced as non-executive Board members
- Shorla speak with Dr. Scott Gottlieb, 23rd FDA Commissioner
- SH-110 Successful FDA Pre-IND Meeting
- Shorla Oncology named Local Enterprise of the Year at The Irish Times Business Awards 2020
- Shorla Oncology closes $8.3M Series A funding round
- Manufacture of first GMP batch of SH-111
- University City Science Center Bootcamp, Philadelphia, USA
- Worldwide Association of MBA’s Best Entrepreneurial Venture Award (Private Sector) 2020
- J.P. Morgan Annual Healthcare Conference, San Francisco, USA
- Sharon and Orlaith featured in the Irish Times Top 50 people to watch in 2020
- SodEXo Women Mean Business (WMB) Female Newcomer Award 2019
- SH-111 Successful FDA pre-IND meeting
- Shorla Oncology featuring in Enterprise Ireland and the Local Enterprise Offices ‘Start’ campaign
- Ireland’s Best Young Entrepreneur 2019
- SH-105 Successful FDA pre-IND meeting
- American Society of Clinical Oncologists (ASCO) Annual Meeting 2019, Chicago, USA
- Network Ireland Tipperary Businesswoman of the year – Emerging New Business AWARD 2019
- Shorla attending MIT-Harvard Medical School Healthcare Innovation Bootcamp, Boston, USA
- Shorla Oncology meet Nancy Pelosi, Madam Speaker of the US House of Representatives
- DCAT New York City, USA
- Biotech Showcase at J.P. Morgan Annual Healthcare Conference, San Francisco, USA
- Shorla Oncology attend Harvard Business School 19th annual Healthcare conference, Boston, USA
- Shorla Oncology visit North Carolina Research Triangle, USA
- Shorla Oncology at SelectUSA Investment Summit, Washington, USA
- Shorla Oncology attending CPhI North America, Philadelphia, USA
- Category: Events
- Category: Media
- Category: Uncategorised
Products
